Discover how RSV vaccines perform in seniors with compromised immunity, especially organ transplant recipients.
Vous n'êtes pas connecté
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of rejection and others with immune system disorders -; do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function.
Discover how RSV vaccines perform in seniors with compromised immunity, especially organ transplant recipients.
FRIDAY, Dec. 27, 2024 -- More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory...
THURSDAY, Jan. 2, 2025 -- Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by...
China is grappling with a significant rise in respiratory illnesses, sparking concerns locally and internationally. Among the viruses spreading are...
LONDON, England – Latest data from the UK Health Security Agency shows the anticipated increase in flu activity over the festive season, as people...
The United States faces a "quad-demic" this winter, with flu, Covid-19, RSV, and norovirus surging due to increased indoor activities, holiday...
The spread of human metapneumovirus (HMPV) has caused global concern, particularly affecting infants, older adults, and those with weakened immunity....
The spread of human metapneumovirus (HMPV) has caused global concern, particularly affecting infants, older adults, and those with weakened immunity....
Human Metapneumovirus (HMPV) is a common virus causing respiratory infections and is particularly severe in young children, the elderly, and those...
An 8-month-old baby in Bengaluru, India, has been diagnosed with the first known case of human metapneumovirus (HMPV) in the country. HMPV, a...